Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts

Arthritis and Rheumatism

Volumn 42, Issue 8, 1999, Pages 1594-1600

  Kullmann, Frank ^a   Judex, Martin ^a   Neudecker, Ingrid ^a   Lechner, Sandra ^a   Jüsten, Hans Peter ^a   Green, Douglas R ^b   Wessinghage, Dieter ^a   Firestein, Gary S ^c   Gay, Steffen ^d   Schölmerich, Jürgen ^a   Müller Ladner, Ulf ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RIBONUCLEASE;

ARTICLE; CLINICAL ARTICLE; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SYNOVIOCYTE; TUMOR SUPPRESSOR GENE;

EID: 0033509412     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199908)42:8<1594::aid-anr5>3.0.co;2-%23     Document Type: Article

References (38)

1. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993;52:S39-47.
2. Müller-Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:675-90.
3. Dooley S, Herlitzka I, Hanselmann R, Ermis A, Henn W, Remberger K, et al. Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis 1996;55: 298-304.
4. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, et al. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 1996;24:141-6.
5. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143-51.
6. Nickels A, Selter H, Pfreundschuh M, Montenarh M, Koch B. Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment. J Clin Pathol 1997;50:654-60.
7. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K. Localisation of apoptosis and expression of apoptosis-related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:442-9.
8. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 1997;94:10895-900.
9. Rème T, Travaglio A, Gueydon E, Adla L, Jorgensen C, Sany J. Mutations of the tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol 1998;111:353-8.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Mancuso T, Aguilar F, Pescarolo MP, Clerico L, Russo P, Parodi S. Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype. Nucleic Acids Res 1997;25:3643-8.
12. Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res 1996;16:3415-22.
13. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993;16:325-32.
14. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
15. Oren M. Lonely no more: p53 finds its kin a tumor suppressor haven. Cell 1997;90:829-32.
16. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, et al. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation, revised formats and visualization tools. Nucleic Acids Res 1998;26:205-13.
17. Béroud C, Soussi T. p53 gene mutation: software and database. Nucleic Acids Res 1998;26:200-4.
18. Harris CC, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993;329:1318-27.
19. Lu X, Lane DP. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 1993;75:765-78.
20. Molès JP, Theillet C, Basset-Seguin N, Guilhou JJ. Mutation of the tumor suppressor gene TP53 is not detected in psoriatic skin. J Invest Dermatol 1993;101:100-2.
21. Kovacs B, Patel A, Dennis G, Tsokos GC. Anti-p53 antibodies in the sera of patients with SLE are not associated with mutations in the p53 gene [abstract]. Arthritis Rheum 1996;39 Suppl 9:S41.
22. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
23. Dolcetti R, Boiocchi M. Cellular and molecular bases of B-cell clonal expansions. Clin Exp Rheumatol 1996;14:S3-13.
24. Han Z, Boyle DL, Shi Y, Green DR, Firestein GS. p53 mutations in rheumatoid arthritis synovium are dominant negative [abstract]. Arthritis Rheum 1998;41 Suppl 9:S238.
25. Müller-Ladner U, Gay RE, Gay S. Cysteine proteases in arthritis and inflammation. In: James MNG, McKerrow JH, editors. Perspectives in drug discovery and design. Leiden, The Netherlands: ESCOM Science Publishers; 1996. p. 87-98.
26. Sevignani C, Wlodarski P, Kirillova J, Mercer WE, Danielson KG, lozzo RV, et al. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene. J Clin Invest 1998;101: 1572-80.
27. Sun Y, Sun YI, Wenger L, Brinckerhoff CE, Cheung HS. p53 down-regulates human metalloproteinase-1 (collagenase-1) gene expression [abstract]. Arthritis Rheum 1998;41 Suppl 9:S275.
28. Müller-Ladner U, Kriegsmann J, Franklin B, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
29. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86:2766-70.
30. Bosari S, Marchetti A, Buttitta F, Graziani D, Borsani G, Loda M, et al. Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis: a comparative study of radioactive and nonradioactive silver-stained SSCP analysis. Diagn Mol Biol 1995;4:249-55.
31. Van Rensburg EJ, Engelbrecht S, van Heerden WF, Kotze MJ, Raubenheimer EJ. Detection of p53 gene mutations in oral squamous cell carcinomas of a black African population sample. Hum Mutat 1998;11:39-44.
32. Kang YK, Kim CJ, Kim WH, Kim HO, Kang GH, Kim YI. p53 mutation and overexpression in hepatocellular carcinoma and dysplastic nodules in the liver. Virchows Arch 1998;432:27-32.
33. Lavarino C, Corletto V, Mezzelani A, Della Torre G, Bartoli C, Riva C, et al. Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma. Br J Cancer 1998;77:125-30.
34. Shi XB, Bodner SM, deVere-White RW, Gumerlock PH. Identification of p53 mutations in archival prostate tumors: sensitivity of an optimized single-strand conformation polymorphism (SSCP) assay. Diagn Mol Pathol 1996;5:271-8.
35. Yagi OK, Akiyama Y, Nomizu T, Iwama T, Endo M, Yuasa Y. Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers, but not in adenomas. Gastroenterology 1998;114:268-74.
36. Wang YC, Chen CY, Chen SK, Cheng SH, Ho WL, Lee H. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Cancer Res 1998;58:328-33.
37. Clark PA, Lester T, Genet S, Jones AM, Hendriks R, Levinsky RL, et al. Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2Rγ chain by single-strand conformation polymorphism analysis. Hum Genet 1995;96:427-34.
38. Puck JM, Pepper AE, Henthorn PS, Candotti F, Isakov J, Whitwam T, et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 1997;89:1968-77.